Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed.
View Article and Find Full Text PDFThe analysis of molecular mechanisms of disease progression challenges the development of bioinformatics tools and omics data integration [...
View Article and Find Full Text PDF